Home > Journals > Journal of Microbiology and Related Research

Journal of Microbiology and Related Research

Submit your article Read this Journals View all journals
Full Text (PDF)
Original Article

Uncomplicated Plasmodium Vivax Malaria Treatment in India

Arvind Nath

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Journal of Microbiology and Related Research 8(1):p 9-10, January-June 2022. | DOI: https://doi.org/10.21088/jmrr.2395.6623.8122.1

How Cite This Article:

Arvind Nath/Uncomplicated Plasmodium Vivax Malaria Treatment in India/J Microbiol Relat Res. 2022;8(1): 9–10

Timeline

Received : May 13, 2022         Accepted : June 01, 2022          Published : June 25, 2022

Abstract

Background: Uncomplicated P. vivax Malaria treatment in India is straightforward because the same regime exists for the North-eastern part of the country and the rest of the country unlike treating uncomplicated P. falciparum Malaria where different regimes exist for these two areas. However, a slightly different approach is needed for the treatment of pregnant patients. oBjectives: To find out what are the antimalarials prescribed in India for treating uncomplicated Vivax Malaria. Methods: By reviewing documents prepared by WHO and NVBDCP. results: It is found that the same regime exists for treating uncomplicated Vivax Malaria whether the patient comes from any part of the country. However, some modifications are made depending on the pregnancy status of the female patient. conclusions: Some more education is required among health care providers on how to treat uncomplicated P. vivax Malaria. This paper addresses this concern.

References

  • 1.   Government of India.(2014). Guidelines for Diagnosis and Treatment of Malaria in India 2014. Available at https:// nvbdcp.gov.in/ Write Read Data/l892s/ 20627628441542176662.pdf Accessed on 29 December 2021.
  • 2.   World Health Organization (2015). Guidelines for the Treatment of Malaria 3rd Edition. Global Malaria Program, World Health Organization, Geneva. Pg. 64. Available at https://apps.who.int/iris/ bitstream/handle/10665/162441/9789241549127_ eng.pdf Accessed on 30 December 2021.
  • 3.   Government of India. (2013) National Drug Policy on Malaria 2013. Available at https://nvbdcp. gov.in/Write Read Data/l892s/ National-Drug - Policy-2013.pdf Accessed on 14 September 2021.
  • 4.   Government of India (2016) Operational Manual for Malaria Elimination in India 2016 (Version 1). Available at https://nvbdcp.gov.in/ WriteReadData/l892s/5232542721532941542.pdf Accessed on 4 August 2021.
  • 5.   Government of India. National Framework for Malaria Elimination in India 2016 – 2030. Available athttps://nvbdcp.gov.in/WriteReadData/l892s/ National - framework - for - malaria - elimination - in - India - 2016%E2%80%932030.pdf Accessed on 11 February 2016.
  • 6.   World Health Organization. Global Technical Strategy for Malaria 2016 – 2030. Available athttps://www.who.int/ publications /i/item/ 9789240031357 Accessed on 17 September 2021.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.

About this article

Cite this article

Arvind Nath/Uncomplicated Plasmodium Vivax Malaria Treatment in India/J Microbiol Relat Res. 2022;8(1): 9–10

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Received Accepted Published
May 13, 2022 June 01, 2022 June 25, 2022
DOI: https://doi.org/10.21088/jmrr.2395.6623.8122.1

Keywords

MalariaPlasmodium vivaxChloroquinePrimaquineHypnozoite

Article Level Metrics

Last Updated

Monday 21 September 2026, 14:27:16 (IST)

1469

Accesses

4
188
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received May 13, 2022
Accepted June 01, 2022
Published June 25, 2022

licence

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share